|
|
|
| 20 August 1998, Volume 17, Number 7, Pages 877-887 |
| Table of contents Previous Abstract Next Article PDF |
 |
| Original article |
| Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a Protein kinase C-mediated pathway |
 |
| A Cadoret1, S Baron-Delage1, F Bertrand1, M Kornprost1, A Groyer2, C Gespach3, J Capeau1 and G Cherqui1,a |
 |
1INSERM U.402, Laboratoire de Biologie Cellulaire, Faculté de Médecine Saint-Antoine, 27, rue Chaligny, 75571 Paris Cédex 12, France
2INSERM U.327, Faculté de Médecine Xavier Bichat, 16, rue Henri Huchard 75018 Paris, France
3INSERM U.482, Hôpital Saint-Antoine, 75571 Paris Cédex 12, France
|
 |
aAuthor for correspondence |
 |
| Abstract |
 | We previously reported that ras and polyoma middle T (PyMT), a constitutive activator of the src proto-oncogene product, up-regulated Caco-2 cell proliferation along with protein kinase C (PKC) alpha expression and PKC activity. We aimed to investigate whether oncogene-induced up-regulation of Caco-2 cell proliferation involved stimulation of the autocrine IGF-II/IGF-I receptor (IGF1R) loop described in these cells and if so, to analyse the role of overexpressed and activated PKC. Compared with control vector transfected Caco-2 cells, ras- and PyMT-transfected cells exhibited increased expression of the 6.0 and 4.8 kb IGF-II transcripts. This was due to increased activity of the P3 and P4 promoters of the IGF-II gene which correlated with increased expression and DNA-binding activity of Sp1, a transcription factor interacting with several specific sites in P3 and P4 promoters. Oncogene-transfected cells displayed enhanced autocrine IGF-II production, which was fully responsible for the oncogene-induced increase in their proliferation since this increase was blunted by anti-human IGF-II and IGF1R ( IR3) antibodies. PKC mediated oncogene activation of the IGF-II gene presumably through action on Sp1 since (i) PKC activation by phorbol 12-myristate 13-acetate increased Sp1 expression, P3 and P4 activity and IGF-II mRNA in control but not in oncogene-transfected cells; and (ii) PKC inhibition by the PKC inhibitor Gö6976 reduced Sp1, P3 and P4 activity and IGF-II mRNA in all three cell lines. This is the first evidence that ras- and PyMT/src oncogenes up-regulate Caco-2 cell proliferation through a PKC-mediated pathway which stimulates IGF-II gene transcription and thereby increases autocrine IGF-II production. The mechanisms underlying IGF-II gene activation by PKC most probably involve action on Sp1. |
 |
| Keywords |
 | Ha-ras; polyoma middle T; IGF-II gene; PKC; Sp1; Caco-2 cells |
|
 |
 |
 |
| Received 8 October 1997; revised 31 March 1998; accepted 31 March 1998 |
 |
| 20 August 1998, Volume 17, Number 7, Pages 877-887 |
| Table of contents Previous Abstract Next Article PDF |
|
|